Skip to content
Skip to content
U.S. National Institutes of Health |
www.cancer.gov
August 19, 2008 • Volume 5 / Number 17
E-Mail This Document
|
Download PDF
|
Bulletin Archive/Search
|
Subscribe
Bulletin Home
Director's Update
The Dawn of Personalized Oncology
Mobilizing National Drug Discovery
Personalized Drug Development
A New Paradigm for Drug Discovery
Treatment Arsenal Expands with Small Chemicals
CMap Extends Drug Use
Clinical Trials and Personalized Drugs
The PPWG
Collaborating with Industry to Drive Drug Development
Helping Technology Collaborations Flourish
Other Resources
Cancer Research Highlights
Breast Cancer Relapse Risk Low after Chemotherapy or Tamoxifen
Novel Monoclonal Antibody Effective in Some Relapsed NHL Patients
Cord-Blood Transplant into Bone Restores Blood Counts
Esophageal Adenocarcinoma Rates Rise in Men and Women
Suicide Risk Higher in Cancer Patients than the General Population
Vitamin C Injections Slow Tumor Growth in Mice
Bulletin Archive
About the Bulletin
Page Options
Print This Page
Print This Document
View Entire Document
Email This Document
View/Print PDF
Bookmark & Share
< Previous Section
|
Next Section >
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Follow Us:
Twitter
YouTube
Facebook
RSS
Other Versions:
Mobile
|
Español
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov
NIH…Turning Discovery Into Health
®